Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The β5-subunit is a key component of the 26S proteasome, specifically the 20S core particle. It possesses chymotrypsin-like peptidase activity, crucial for the degradation of ubiquitinated proteins. Its inhibition is a therapeutic strategy in cancer treatment. Proper function is essential for cellular homeostasis and stress response.
Inhibition of chymotrypsin-like peptidase activity of the 26S proteasome, leading to accumulation of ubiquitinated proteins and induction of apoptosis in cancer cells.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 26S Proteasome β5-Subunit (β5-subunit).